FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Peter Elliott

Research Profile

Chemicals & Drugs

Living Beings

Disorders

Procedures

Drug Screening Assays, Antitumor

Co-author Network

Publications

TOP 3
Peter J Elliott; Thomas M Zollner; Wolf-Henning Boehncke
Proteasome inhibition: a new anti-inflammatory strategy.
Joseph Pye; Farhad Ardeshirpour; Arlene McCain; Dwight A Bellinger; Elizabeth P Merricks; Julian Adams; Peter J Elliott; Christine S Pien; Thomas H Fischer; Albert S Baldwin; Timothy C Nichols
Proteasome inhibition ablates activation of NF-kappa B in myocardial reperfusion and reduces reperfusion injury.
Peter J Elliott; Teresa A Soucy; Christine S Pien; Julian Adams; Eric S Lightcap
Assays for proteasome inhibition.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Peter Elliott (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2003: Peter J Elliott; Thomas M Zollner; Wolf-Henning Boehncke
Proteasome inhibition: a new anti-inflammatory strategy.
Journal of molecular medicine (Berlin, Germany) 2003;81(4):235-45.
2003: Joseph Pye; Farhad Ardeshirpour; Arlene McCain; Dwight A Bellinger; Elizabeth P Merricks; Julian Adams; Peter J Elliott; Christine S Pien; Thomas H Fischer; Albert S Baldwin; Timothy C Nichols
Proteasome inhibition ablates activation of NF-kappa B in myocardial reperfusion and reduces reperfusion injury.
American journal of physiology. Heart and circulatory physiology 2003;284(3):H919-26.
2003: Peter J Elliott; Teresa A Soucy; Christine S Pien; Julian Adams; Eric S Lightcap
Assays for proteasome inhibition.
Methods in molecular medicine 2003;85():163-72.
2002: Robert Z Orlowski; Thomas E Stinchcombe; Beverly S Mitchell; Thomas C Shea; Albert S Baldwin; Stephanie Stahl; Julian Adams; Dixie Esseltine; Peter J Elliott; Christine S Pien; Roberto Guerciolini; Jessica K Anderson; Natalie D Depcik-Smith; Rita Bhagat; Mary Jo Lehman; steven novick; Owen A O'Connor; Steven L Soignet
Phase I trial of the proteasome inhibitor PS-341 in patients with refractory hematologic malignancies.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(22):4420-7.
2002: Carol Aghajanian; Steven L Soignet; Don S Dizon; Christine S Pien; Julian Adams; Peter J Elliott; Paul Sabbatini; Vincent A Miller; Martee Hensley; Sandra Pezzulli; Christina Canales; Adil Daud; David Spriggs
A phase I trial of the novel proteasome inhibitor PS341 in advanced solid tumor malignancies.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(8):2505-11.
2002: Thomas M Zollner; Maurizio Podda; Christine S Pien; Peter J Elliott; Roland Kaufmann; Wolf-Henning Boehncke
Proteasome inhibition reduces superantigen-mediated T cell activation and the severity of psoriasis in a SCID-hu model.
The Journal of clinical investigation 2002;109(5):671-9.
2001: Teru Hideshima; Paul Richardson; Dharminder Chauhan; Vito J Palombella; Peter J Elliott; Julian Adams; Kenneth C Anderson
The proteasome inhibitor PS-341 inhibits growth, induces apoptosis, and overcomes drug resistance in human multiple myeloma cells.
Cancer research 2001;61(7):3071-6.
2000: Julian Adams; Vito J Palombella; Peter J Elliott
Proteasome inhibition: a new strategy in cancer treatment.
Investigational new drugs 2000;18(2):109-21.
2000: Eric S Lightcap; TA McCormack; Christine S Pien; Vincent Chau; Julian Adams; Peter J Elliott
Proteasome inhibition measurements: clinical application.
Clinical chemistry 2000;46(5):673-83.
1999: Peter J Elliott; Christine S Pien; TA McCormack; I D Chapman; Julian Adams
Proteasome inhibition: A novel mechanism to combat asthma.
The Journal of allergy and clinical immunology 1999;104(2 Pt 1):294-300.
1999: DD Lazarus; AT Destree; LM Mazzola; TA McCormack; LR Dick; B Xu; J Q Huang; JW Pierce; Margaret A Read; MB Coggins; V Solomon; A L Goldberg; SJ Brand; Peter J Elliott
A new model of cancer cachexia: contribution of the ubiquitin-proteasome pathway.
The American journal of physiology 1999;277(2 Pt 1):E332-41.
1999: Julian Adams; Vito J Palombella; Edward A Sausville; J Johnson; AT Destree; DD Lazarus; J Maas; Christine S Pien; S Prakash; Peter J Elliott
Proteasome inhibitors: a novel class of potent and effective antitumor agents.
Cancer research 1999;59(11):2615-22.
1999: Matthew B Grisham; Vito J Palombella; Peter J Elliott; EM Conner; SJ Brand; H L Wong; Christine S Pien; LM Mazzola; AT Destree; Lana Parent; Julian Adams
Inhibition of NF-kappa B activation in vitro and in vivo: role of 26S proteasome.
Methods in enzymology 1999;300():345-63.
1998: Vito J Palombella; EM Conner; John W Fuseler; AT Destree; J M Davis; F Stephen Laroux; Robert E Wolf; J Huang; SJ Brand; Peter J Elliott; DD Lazarus; TA McCormack; Lana Parent; R Stein; Julian Adams; Matthew B Grisham
Role of the proteasome and NF-kappaB in streptococcal cell wall-induced polyarthritis.
Proceedings of the National Academy of Sciences of the United States of America 1998;95(26):15671-6.